BioSpace News Archive

Business

BerGenBio ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast

BerGenBio ASA, will announce its results for the third quarter on Tuesday 19 November 2019.

November 7, 2019
·
2 min read
Business

FIND Collaborates with SpeeDx and QuantuMDx

Investigating feasibility of rapid, low-cost STI diagnostics development.

November 7, 2019
·
4 min read
Deals

Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases

Experienced team focused initially on genetically-defined, early onset form of dementia with potential to delay the onset of symptoms and disease progression

November 7, 2019
·
4 min read
Deals

TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million

Dedicated to Developing and Commercializing Innovative Oncology Drugs and Therapies Propelling Future Growth

November 7, 2019
·
8 min read
Business

EyePoint Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Corporate Progress

U.S. commercial launch trajectory for DEXYCU® and YUTIQ® gains momentum with strong customer order growth over Q2

November 7, 2019
·
16 min read
Business

Genesis HealthCare Reports Third Quarter 2019 Results

Genesis Healthcare, Inc., one of the largest post-acute care providers in the United States, announced operating results for the third quarter ended September 30, 2019.

November 7, 2019
·
30 min read
Deals

Evolus Announces Pricing of Public Offering of Common Stock at $13.00 per share

Evolus, Inc. announced the pricing of its public offering of 5,217,000 shares of its common stock at a public offering price of $13.00 per share, before underwriting discounts and commissions.

November 7, 2019
·
4 min read
BioMidwest

GenomOncology’s Precision Oncology Platform to be implemented at Nationally Recognized Academic Medical Center

GenomOncology, LLC announced that it was selected by the Duke Cancer Institute to utilize GO’s Precision Oncology Platform to provide real-time therapeutic, prognostic, and clinical trial recommendations to molecular tumor board organizers and participants at Duke Cancer Institute.

November 7, 2019
·
1 min read
Business

BioNTech to Report Third Quarter 2019 Financial Results and Operational Progress on November 14, 2019

BioNTech SE, a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases, will announce on Thursday, November 14th, 2019 its financial results for the third quarter ended September 30, 2019.

November 7, 2019
·
1 min read
Business

Leica Microsystems and Precision Lens Sign Agreement to Expand Leica Ophthalmic Portfolio Market Opportunity in the U.S. Midwest

Largest distributor of ophthalmic products in the Midwest to expand Leica Microsystems’ ability to serve strategic accounts and accelerate growth

November 7, 2019
·
3 min read